Corvus Pharmaceuticals, Inc.·4

Dec 16, 4:11 PM ET

Buggy Joseph J 4

4 · Corvus Pharmaceuticals, Inc. · Filed Dec 16, 2019

Insider Transaction Report

Form 4
Period: 2019-12-12
Buggy Joseph J
EVP Discovery Research
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-12+40,00040,000 total
    Exercise: $3.54Exp: 2029-12-12Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4